Tel:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@anticorps-enligne.fr

HLA-B Kit ELISA (Major Histocompatibility Complex, Class I, B) Kit ELISA

HLA-B Reactivité: Humain Colorimetric Sandwich ELISA 1.56-100 ng/mL
N° du produit ABIN2043915
$982.14
Plus shipping costs $45.00
96 tests
local_shipping Destination: Etats-Unis
Envoi sous 16 à 21 jours ouvrables
  • Antigène
    Reactivité
    Humain
    Méthode de détection
    Colorimetric
    Type de méthode
    Sandwich ELISA
    Gamme de detection
    1.56-100 ng/mL
    Seuil minimal de détection
    1.56 ng/mL
    Application
    ELISA
    Marque
    BioAssay™
    Sensibilité
    < 0.63 ng/mL
  • Plaque
    Pre-coated
    Protocole
    Major Histocompatibility Complex Class I B (MHCB) BioAssay-ELISA Kit (Human) is a Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Major Histocompatibility Complex Class I B (MHCB). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Major Histocompatibility Complex Class I B (MHCB). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Major Histocompatibility Complex Class I B (MHCB), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm±10nm. The concentration of Major Histocompatibility Complex Class I B (MHCB) in the samples is then determined by comparing the O.D. of the samples to the standard curve.
    Restrictions
    For Research Use only
  • Stock
    4 °C/-20 °C
  • Antigène
    Autre désignation
    Major Histocompatibility Complex Class I B (MHCB) (HLA-B ELISA Kit Extrait)
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Vous êtes ici: